2nd virus vaccine shows striking success in US tests
More promising news from a COVID-19 vaccine candidate. Moderna now says its shots are showing strong protection against the virus - 94% efficacy. This, after Pfizer just last week announced its vaccine is also showing over 90% efficacy.
Moderna said Monday its #Covid-19 #vaccine is proving to be highly effective in a major #trial, a second dash of hope in the global race for a shot to tame a resurgent virus that is now killing more than 8,000 people a day worldwide. Moderna is seeking approval of its coronavirus vaccine in the US and Europe so it can be recommended for widespread use.
Regulators will decide if it is safe and effective enough to be rolled out.
Clinical studies show the jab is more than 94% effective at protecting people from becoming ill with Covid-19.
Pfizer, which has a similar jab, has already filed for the same US approval. President Donald Trump dangled a promise to restore "normal life" as he looked to campaign past the political damage of the pandemic. He was speaking in Minnesota for his third rally of the day, making his final pitch before Tuesday's election. (Oct. 30) President Donald Trump is asserting that even without a virus vaccine, "we're rounding the turn," he said at a rally in New Hampshire on Sunday. But data shows new COVID-19 cases are at an all-time high, with 83,718 cases reported Saturday. (Oct. 25)